Revenue: The sum of all revenue fields included for a company's operating activities.
Virax Biolabs Group Limited (VRAX) had Revenue of $0.16M for the most recently reported fiscal year, ending 2024-03-31.
Income Statement Financials | |
Revenue |
$0.16M |
$-6.73M |
|
$0.11M |
|
$0.05M |
|
$6.65M |
|
$-6.50M |
|
$-0.24M |
|
$-6.74M |
|
$-6.74M |
|
$-6.74M |
|
$-6.74M |
|
$-6.74M |
|
$-6.74M |
|
$-6.50M |
|
$-6.39M |
|
2.01M |
|
2.01M |
|
$-3.36 |
|
$-3.36 |
|
Balance Sheet Financials | |
$4.38M |
|
$0.90M |
|
$1.10M |
|
$5.48M |
|
$0.17M |
|
-- |
|
$0.18M |
|
$0.35M |
|
$5.14M |
|
$5.14M |
|
$5.14M |
|
2.57M |
|
Cash Flow Statement Financials | |
$-6.25M |
|
$-1.16M |
|
$1.65M |
|
$9.35M |
|
$3.59M |
|
$-5.76M |
|
$1.01M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
25.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
32.34% |
|
-4153.25% |
|
-4153.25% |
|
-4087.34% |
|
-4308.38% |
|
-4304.81% |
|
$-7.20M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.75 |
|
0.72 |
|
508.33 |
|
-131.14% |
|
-131.14% |
|
-122.89% |
|
-131.14% |
|
$2.00 |
|
$-3.59 |
|
$-3.11 |